The rapid global adoption of GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) is reshaping consumer health markets in unexpected ways. One of the most significant — and least talked about — knock-on effects is a surge in demand for soluble fibre supplements, particularly psyllium husk.

The GLP-1 Side Effect Few People Talk About

GLP-1 medications work in part by slowing gastric emptying and reducing appetite. This dramatic change in eating patterns frequently leads to constipation, irregular bowel movements, and gastrointestinal discomfort. Clinical literature consistently identifies these as among the most common side effects of GLP-1 therapy.

The traditional medical recommendation? Increase soluble fibre intake. And the most clinically validated, FDA-recognized soluble fibre is psyllium husk — the only fibre with an FDA-authorized health claim for cholesterol reduction.

What This Means for Psyllium Demand

Major supplement brands have noticed. Psyllium-based fibre supplements have seen accelerating growth in both prescription-adjacent retail (pharmacies near GLP-1 prescribers) and direct-to-consumer wellness channels. Search interest for "psyllium for Ozempic" and similar terms has grown substantially since 2024.

This isn't a fad. GLP-1 medication usage is projected to continue expanding through the late 2020s as new molecules enter the market and oral formulations reduce barriers to adoption. Every new GLP-1 user is, statistically, a future fibre supplement consumer.

Implications for the Psyllium Supply Chain

For psyllium exporters, this trend creates both opportunity and pressure:

  • Higher purity demand: Premium supplement brands serving GLP-1 users want 99% purity grades, not commodity 85%
  • Capsule-grade powder: Demand for 60-80 mesh powder for capsule filling is rising faster than whole husk
  • Clean-label sterilization: Steam-treated psyllium is preferred for the wellness market that resists irradiation labelling
  • Organic premium: Health-conscious GLP-1 users are willing to pay premiums for certified organic psyllium
  • Tighter QA expectations: Pharma-grade COAs and EU compliance are increasingly expected, not just nice-to-have

How Sigma Global Is Positioned

Sigma Global supplies all four product categories driven by this trend — high-purity husk (98–99%), fine-mesh powder (60–100), certified organic, and dual-sterilization options. Our independent lab testing and EU compliance readiness align with what pharma-adjacent supplement brands now require from their psyllium suppliers.

If you're building or expanding a fibre supplement product line for the GLP-1 wellness market, we'd like to hear from you.

Trial orders from 500 kg let you test multiple grades without bulk commitment.